Roche Agrees to Develop Weight-Loss Therapy With Zealand Pharma
The companies agreed to share profits for the therapy equally in the U.S. and Europe, but Roche will have exclusive rights to ...
Spark Therapeutics, a Philly biotech pioneer, is being restructured amid financial write-downs
The changes at Spark follow Roche's decision last year to halt development of a gene therapy for hemophilia A that was the ...
STAT3d
Pharmalittle: We’re reading about a Roche deal for an obesity drug, a Gilead HIV drug and more
the current widely prescribed type of medicine aimed at obesity and diabetes. Roche has been making the case that the obesity market is large enough for it to enter the field, if a bit later than ...
Fierce Pharma11d
Roche gains label expansion for heart attack medicine TNKase to treat acute ischemic stroke
Genentech has had the lone medicine on the market for the acute treatment of stroke. | Over nearly the last three decades, ...
pharmaphorum9d
FDA starts review of Roche's Gazyva in lupus nephritis
The US regulator has started a review of Roche's supplemental biologics license application (BLA) for Gazyva/Gazyvaro ...